Targeted Diagnostics & Therapeutics is Decision/Risk Analysis in United States that focus on developer business. Founded in 1994. They cover business area such as developer, therapeutic, diagnosis, treatment, colorectal cancer, lymph node, patient, surgical staging, doctor, information, decision, chemotherapy, disease-free survival.
1994
( 30 years old in 2024 )
Developer
-
1045 Andrew Drive
West Chester, PA 19380
United States
Private
developertherapeuticdiagnosistreatmentcolorectal cancerlymph nodepatientsurgical stagingdoctorinformationdecisionchemotherapydisease-free survival
* We use standard office opening hours in near Targeted Diagnostics & Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Targeted Diagnostics & Therapeutics is Decision/Risk Analysis business from United States that founded in 1994 (30 years old in 2024), Targeted Diagnostics & Therapeutics business is focusing on Developer.
Targeted Diagnostics & Therapeutics headquarter office and corporate office address is located in 1045 Andrew Drive West Chester, PA 19380 United States.
Targeted Diagnostics & Therapeutics was founded in United States.
In 2024, Targeted Diagnostics & Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Targeted Diagnostics & Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
